Miopía magna: características clínicas, diagnóstico y estrategias terapéuticas

• Autores: Blanca Montori Lacámara, Sara Marquina Martín, Marta Sancho Larraz, Aser Cebollada Martínez, Carla Sierra Santamaria
• Localización: Revista Sanitaria de Investigación, ISSN-e 2660-7085, Vol. 6, Nº. 5, 2025
• Idioma: español
• Enlaces
  • Texto completo
• Resumen
  • español

    La miopía magna es una condición ocular severa que se encuentra entre las principales causas de discapacidad visual y ceguera en el mundo. Su prevalencia está asociada con complicaciones graves como el desprendimiento de retina y la maculopatía miópica. Diversos factores, tanto genéticos como ambientales y relacionados con el estilo de vida, influyen en su progresión.

    Debido a su carácter degenerativo y debilitante, la miopía degenerativa representa un reto clínico exigiendo un seguimiento oftalmológico riguroso y un enfoque terapéutico personalizado.

  • English

    High myopia is a severe ocular condition that ranks among the leading causes of visual impairment and blindness worldwide. Its prevalence is associated with serious complications such as retinal detachment and myopic maculopathy. Various factors, including genetic predisposition, environmental influences, and lifestyle habits, contribute to its progression.

    Due to its degenerative and debilitating nature, pathological myopia presents a significant clinical challenge, requiring rigorous ophthalmologic monitoring and a personalized therapeutic approach.

• Referencias bibliográficas
  • Wolffsohn JS, Flitcroft DI, Gifford KL, et al. IMI – Myopia Control Reports Overview and Introduction. Invest Ophthalmol Vis Sci. 2019;60(3):M1-M19....
  • Flitcroft DI, He M, Jonas JB, et al. IMI – Defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies....
  • Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31(6):622-660....
  • Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet. 2012;379(9827):1739-1748. doi:10.1016/S0140-6736(12)60272-4.
  • Tideman JW, Snabel MC, Tedja MS, et al. Association of axial length with risk of uncorrectable visual impairment for Europeans with myopia....
  • Holden BA, Jong M, Davis S, et al. The global epidemic of myopia: trends, drivers, and projections. Ophthalmology. 2016;123(5):1036-1042....
  • Soubrane G, Coscas GJ. Choroidal Neovascular Membrane in Degenerative Myopia. In: Ryan SJ, Schachat AP, eds. Retina. 4th ed. Philadelphia:...
  • Ikuno Y. Overview of the Complications of High Myopia. Retina. 2017;37(12):2347-2351. doi:10.1097/IAE.0000000000001489.
  • Curtin BJ. The Myopias: Basic Science and Clinical Management. Harper & Row; 1985.
  • Blach RK. Degenerative myopia. En: Krill AE, Archer D, eds. Hereditary retinal and choroidal diseases. Hagerstown: Harper & Row; 1977....
  • Ohno-Matsui K, Ikuno Y, Lai TY, Simó R. Myopia: A Clinical Update. Prog Retin Eye Res. 2016;52:1-19. doi:10.1016/j.preteyeres.2015.10.002.
  • Spaide RF, Ohno-Matsui K, Yannuzzi LA. Pathologic Myopia. Springer; 2012.
  • Grossniklaus HE, Green WR. Pathologic findings in pathologic myopia. Retina. 1992;12(2):127-133.
  • Flaxel CJ, et al. Myopia and the Risk of Myopic Macular Degeneration. Ophthalmology. 2013;120(6):1248-1252. doi:10.1016/j.ophtha.2012.10.009.
  • Wu PC, et al. The role of optical coherence tomography in the management of myopic macular degeneration. Ophthalmol Ther. 2015;4(2):91-102....
  • Sung HJ, et al. Anti-VEGF Therapy for Myopic Choroidal Neovascularization. Ophthalmology. 2014;121(3):632-638. doi:10.1016/j.ophtha.2013.08.003.
  • Laud K, et al. Vitrectomy in myopic macular retinal detachment: outcomes and risk factors. Am J Ophthalmol. 2019;198:163-171. doi: 10.1016/j.ajo.2018.11.020.